Results 161 to 170 of about 28,985 (310)

Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC. [PDF]

Oncoscience
Tiwari B, Koirala A.
europepmc   +1 more source

Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanoma

International Journal of Cancer, EarlyView.
What's New? Uveal melanoma is the most common primary intraocular cancer in adults, and up to half of patients develop metastatic disease, predominantly in the liver, where prognosis remains poor despite promising treatment options. In this study, the authors evaluated the safety and efficacy of administering systemic therapy within 40 days of liver ...
Patrick Kasteleiner, Gerd Grözinger, Jörg Schmehl, Lukas Flatz, Andrea Forschner   +4 more
wiley   +1 more source

Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments. [PDF]

Front Oncol
Haykal D, Rossi A, Kerob D, Dréno B.
europepmc   +1 more source

Real‐world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study

International Journal of Cancer, EarlyView.
What's New? Although patients with melanoma brain metastases (MBM) may benefit from treatment with immune checkpoint inhibitors (ICIs), which are known to improve survival in advanced melanoma, MBM patients have often been excluded from trials evaluating ICIs.
Ralf Gutzmer, Michael Weichenthal, Thomas Eigentler, Peter Mohr, Thomas Sickmann, Pia Dücker, Christoffer Gebhardt, Sebastian Haferkamp, Katharina C. Kähler, Friedegund Meier, Claudia Pföhler, Anca Sindrilaru, Patrick Terheyden, Imke von Wasielewski, Selma Ugurel, Jens Ulrich, Jochen Utikal, Carsten Weishaupt, Dirk Schadendorf   +18 more
wiley   +1 more source

Prevention and Management of Dermatologic Adverse Events in Patients Treated with Amivantamab Plus Lazertinib. [PDF]

Curr Oncol
Szwed C, Blicharz L, Knetki-Wroblewska M, Rudnicka L, Czuwara J.   +4 more
europepmc   +1 more source

Efficacy of energy‐based devices on episiotomy pain and healing: A systematic review and meta‐analysis

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Episiotomy is a common obstetric procedure often associated with significant postpartum pain and delayed wound healing. Conventional treatments provide limited relief and might not be suitable for all women. Energy‐based therapies, including infrared irradiation and low‐level laser therapy (LLLT), a non‐thermal photo biomodulation ...
Shira Regev‐Sadeh, Chen Nahshon, Nadav Cohen, Ofer Lavie, Ariel Zilberlicht   +4 more
wiley   +1 more source

Comparative Safety of Six First-Line Antiepileptic Monotherapies in Pediatric Epilepsy Using the United States FDA Adverse Event Reporting System. [PDF]

Cureus
Ogura T, Shiraishi C.
europepmc   +1 more source

High‐Frequency Ultrasonographic Characterization of Subcutaneous Glomus Tumors

Journal of Clinical Ultrasound, EarlyView.
Color Doppler image reveals intralesional hypervascularity. ABSTRACT Objective To evaluate the clinical manifestations and ultrasonographic characteristics of glomus tumors under the nails and other subcutaneous soft tissues. Methods A retrospective analysis was performed on 45 patients with pathologically confirmed glomus tumors who underwent ...
Mingyu Bai, Nan Wang, Jie Jiang
wiley   +1 more source

Not All GLP-1 Receptor Agonists Are Alike: Real-World Evidence of Differential Endocrine and Dermatologic Safety. [PDF]

Diabetes Metab Res Rev
Lee N, Kim Y.
europepmc   +1 more source

Sex differences in 5‐year incidence and prevalence of physical illnesses following early childhood autism diagnosis

JCPP Advances, EarlyView.
Abstract Background Sex differences in the clinical presentation of autism are established, but evidence on early‐life co‐occurring physical illnesses in early‐diagnosed autistic individuals is scarce. This nationwide cohort study examined sex‐stratified incidence of physical illnesses within 5 years after autism spectrum disorder (ASD) diagnosis in ...
Yu‐Chieh Chuang, Yu‐Jui Huang, Meng‐Chuan Lai, Wen‐Yin Chen, Chun‐Hung Pan, Sheng‐Siang Su, Chian‐Jue Kuo   +6 more
wiley   +1 more source